Candel Therapeutics (CADL) Short Interest Ratio & Short Volume → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free CADL Stock Alerts $11.98 +0.48 (+4.17%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Candel Therapeutics Short Interest DataCurrent Short Interest1,050,000 sharesPrevious Short Interest2,030,000 sharesChange Vs. Previous Month-48.28%Dollar Volume Sold Short$7.40 millionShort Interest Ratio0.2 Days to CoverLast Record DateApril 30, 2024Outstanding Shares29,750,000 sharesFloat Size15,660,000 sharesShort Percent of Float6.70%Today's Trading Volume498,005 sharesAverage Trading Volume3,610,356 sharesToday's Volume Vs. Average14% Short Selling Candel Therapeutics ? Sign up to receive the latest short interest report for Candel Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCADL Short Interest Over TimeCADL Days to Cover Over TimeCADL Percentage of Float Shorted Over Time Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Candel Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,050,000 shares $7.40 million -48.3%6.7%0.2 $7.05 4/15/20242,030,000 shares $11.81 million +1,161.7%13.0%0.4 $5.82 3/31/2024160,900 shares $254,222.00 +9.2%1.0%0 $1.58 3/15/2024147,300 shares $220,950.00 -24.7%1.0%1.7 $1.50 2/29/2024195,600 shares $363,816.00 -30.4%1.3%0.3 $1.86 2/15/2024281,200 shares $489,288.00 +69.2%1.8%0.5 $1.74 Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024166,200 shares $216,060.00 -10.9%1.1%0.3 $1.30 1/15/2024186,600 shares $248,178.00 -9.2%1.2%0.3 $1.33 12/31/2023205,400 shares $301,938.00 -54.9%1.3%0.4 $1.47 12/15/2023455,500 shares $610,370.00 +1,071.0%2.9%0.8 $1.34 11/30/202338,900 shares $34,971.10 -5.8%0.3%1.3 $0.90 11/15/202341,300 shares $40,350.10 -40.8%0.3%1.3 $0.98 10/31/202369,800 shares $62,813.02 -56.4%0.4%2.3 $0.90 10/15/2023159,900 shares $143,910.00 -0.8%1.0%7.2 $0.90 9/30/2023161,200 shares $148,304.00 +0.5%1.0%8.8 $0.92 9/15/2023160,400 shares $202,104.00 -2.1%1.0%8.2 $1.26 8/31/2023163,900 shares $199,958.00 +1.2%1.0%9 $1.22 8/15/2023162,000 shares $187,920.00 -5.9%1.0%8.3 $1.16 7/31/2023172,100 shares $185,868.00 +8.6%1.0%8.8 $1.08 7/15/2023158,500 shares $183,860.00 -4.4%1.0%7.2 $1.16 6/30/2023165,800 shares $208,908.00 +20.9%1.0%4.9 $1.26 6/15/2023137,200 shares $196,196.00 +9.8%0.8%4.3 $1.43 5/31/2023125,000 shares $188,750.00 -7.3%0.8%3.9 $1.51 5/15/2023134,800 shares $215,680.00 +0.2%0.8%4.4 $1.60 4/30/2023134,500 shares $173,505.00 +163.2%0.8%4.5 $1.29 4/15/202351,100 shares $72,562.00 No Change0.3%1.6 $1.42 3/31/202351,100 shares $68,985.00 +24.3%0.3%2.4 $1.35 3/15/202341,100 shares $61,650.00 +43.7%0.3%1.5 $1.50 2/28/202328,600 shares $51,480.00 +2.1%0.2%0.8 $1.80 2/15/202328,000 shares $56,000.00 +20.7%0.2%0.8 $2.00 1/31/202323,200 shares $59,612.40 -16.6%0.2%0.6 $2.57 1/15/202327,800 shares $57,824.00 -9.5%0.2%0.5 $2.08 12/30/202230,700 shares $54,953.00 -39.8%0.3%0.6 $1.79 12/15/202251,000 shares $96,390.00 +38.6%0.6%1.2 $1.89 11/30/202236,800 shares $64,400.00 -16.0%0.4%1 $1.75 11/15/202243,800 shares $79,278.00 -6.8%0.5%1.2 $1.81 10/31/202247,000 shares $91,180.00 -2.7%0.5%1.2 $1.94 10/15/202248,300 shares $122,682.00 -16.2%0.5%1.5 $2.54 9/30/202257,600 shares $180,864.00 +12.3%0.6%3.1 $3.14 9/15/202251,300 shares $175,959.00 +4.3%0.5%3.1 $3.43**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 8/31/202249,200 shares $170,724.00 -5.0%0.5%3.2 $3.47 8/15/202251,800 shares $181,300.00 -9.4%0.5%3.4 $3.50 7/31/202257,200 shares $177,320.00 -8.9%0.6%4.5 $3.10 7/15/202262,800 shares $209,752.00 -9.8%0.7%3.3 $3.34 6/30/202269,600 shares $225,504.00 +8.4%0.7%1.6 $3.24 6/15/202264,200 shares $222,132.00 -29.0%0.7%1.3 $3.46 5/31/202290,400 shares $340,808.00 +49.9%1.0%1.7 $3.77 5/15/202260,300 shares $241,200.00 +14.4%0.6%1.1 $4.00 4/30/202252,700 shares $188,666.00 -27.1%0.5%1 $3.58 4/15/202272,300 shares $375,237.00 +22.3%0.7%1.3 $5.19 3/31/202259,100 shares $300,819.00 +16.8%0.6%1.6 $5.09 3/15/202250,600 shares $189,750.00 -14.0%0.5%1.4 $3.75 2/28/202258,800 shares $242,256.00 +19.5%0.6%1.4 $4.12 2/15/202249,200 shares $233,208.00 -2.4%0.5%1.2 $4.74 1/31/202250,400 shares $216,216.00 +12.0%0.5%1.1 $4.29 1/15/202245,000 shares $281,250.00 -15.3%0.4%1 $6.25 12/31/202153,100 shares $415,242.00 +46.3%0.5%1.3 $7.82 12/15/202136,300 shares $265,353.00 -13.4%0.4%0.7 $7.31 11/30/202141,900 shares $434,084.00 -13.6%0.4%0.6 $10.36 11/15/202148,500 shares $485,485.00 -38.0%0.5%0.5 $10.01 10/29/202178,200 shares $878,186.00 +18.3%0.8%0.7 $11.23 10/15/202166,100 shares $649,763.00 -27.0%0.6%0.4 $9.83 9/30/202190,600 shares $982,104.00 -34.4%0.9%0.5 $10.84 9/15/2021138,200 shares $1.15 million +128.8%1.4%0.7 $8.32 8/31/202160,400 shares $485,616.00 +571.1%0.6%0.3 $8.04 8/13/20219,000 shares $68,310.00 No Change0.1%0 $7.59 CADL Short Interest - Frequently Asked Questions What is Candel Therapeutics' current short interest? Short interest is the volume of Candel Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,050,000 shares of CADL short. 6.70% of Candel Therapeutics' shares are currently sold short. Learn More on Candel Therapeutics' current short interest. What is a good short interest percentage for Candel Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.70% of Candel Therapeutics' floating shares are currently sold short. Is Candel Therapeutics' short interest increasing or decreasing? Candel Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 1,050,000 shares, a decline of 48.3% from the previous total of 2,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Candel Therapeutics' float size? Candel Therapeutics currently has issued a total of 29,750,000 shares. Some of Candel Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Candel Therapeutics currently has a public float of 15,660,000 shares. How does Candel Therapeutics' short interest compare to its competitors? 6.70% of Candel Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Candel Therapeutics: Jasper Therapeutics, Inc. (5.21%), Black Diamond Therapeutics, Inc. (3.56%), UroGen Pharma Ltd. (18.89%), SOPHiA GENETICS SA (0.11%), Caribou Biosciences, Inc. (13.35%), MeiraGTx Holdings plc (1.76%), Invivyd, Inc. (9.65%), Adaptimmune Therapeutics plc (1.43%), Tenaya Therapeutics, Inc. (5.80%), Poseida Therapeutics, Inc. (9.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Candel Therapeutics stock? Short selling CADL is an investing strategy that aims to generate trading profit from Candel Therapeutics as its price is falling. CADL shares are trading up $0.63 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Candel Therapeutics? A short squeeze for Candel Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CADL, which in turn drives the price of the stock up even further. How often is Candel Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CADL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: JSPR Short Interest BDTX Short Interest URGN Short Interest SOPH Short Interest CRBU Short Interest MGTX Short Interest IVVD Short Interest ADAP Short Interest TNYA Short Interest PSTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CADL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace